BCT:CA Briacell Therapeutics Corp

CAD 2.96 0.01 0.338983
Icon

Briacell Therapeutics Corp (BCT:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | TSX
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 2.96

+0.01 (+0.34)%

CAD 0.05B

800.00

CAD -1.00

CAD 0.00 (-100.00%)

Icon

BCT:CA

Briacell Therapeutics Corp (CAD)
COMMON STOCK | TSX
CAD 2.96
0.00 0
Take a Tour

Briacell Therapeutics Corp (BCT:CA) Stock Forecast

N/A

Based on the Briacell Therapeutics Corp stock forecast from 0 analysts, the average analyst target price for Briacell Therapeutics Corp is not available over the next 12 months. Briacell Therapeutics Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Briacell Therapeutics Corp is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Briacell Therapeutics Corp’s stock price was CAD 2.96. Briacell Therapeutics Corp’s stock price has changed by -6.03% over the past week, -23.71% over the past month and -70.34% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...